 | • レポートコード：MRC2-11QY03493 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は気管支炎薬のグローバル市場について調査・分析したレポートです。種類別（AZD-9668、CG-367、シクロスポリン、HOB-051、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別気管支炎薬の競争状況、市場シェア ・世界の気管支炎薬市場：種類別市場規模 2015年-2020年（AZD-9668、CG-367、シクロスポリン、HOB-051、その他） ・世界の気管支炎薬市場：種類別市場規模予測 2021年-2026年（AZD-9668、CG-367、シクロスポリン、HOB-051、その他） ・世界の気管支炎薬市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅医療） ・世界の気管支炎薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅医療） ・北米の気管支炎薬市場分析：米国、カナダ ・ヨーロッパの気管支炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの気管支炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の気管支炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの気管支炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advanced Inhalation Therapies (AIT) Ltd、AstraZeneca Plc、DBV Technologies SA、F. Hoffmann-La Roche Ltd、Han Wha Pharma Co Ltd、Kyorin Pharmaceutical Co Ltd、Merck & Co Inc、Mucosis BV、Orbis Biosciences Inc、Therabron Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Bronchitis Drug Market
The global Bronchitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bronchitis Drug Scope and Market Size
Bronchitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bronchitis Drug market is segmented into
AZD-9668
CG-367
Cyclosporine
HOB-051
Others
Segment by Application, the Bronchitis Drug market is segmented into
Clinic
Hospital
Homecare
Regional and Country-level Analysis
The Bronchitis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bronchitis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bronchitis Drug Market Share Analysis
Bronchitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bronchitis Drug business, the date to enter into the Bronchitis Drug market, Bronchitis Drug product introduction, recent developments, etc.
The major vendors covered:
Advanced Inhalation Therapies (AIT) Ltd
AstraZeneca Plc
DBV Technologies SA
F. Hoffmann-La Roche Ltd
Han Wha Pharma Co Ltd
Kyorin Pharmaceutical Co Ltd
Merck & Co Inc
Mucosis BV
Orbis Biosciences Inc
Therabron Therapeutics Inc
1 Study Coverage
1.1 Bronchitis Drug Product Introduction
1.2 Market Segments
1.3 Key Bronchitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bronchitis Drug Market Size Growth Rate by Type
1.4.2 AZD-9668
1.4.3 CG-367
1.4.4 Cyclosporine
1.4.5 HOB-051
1.4.6 Others
1.5 Market by Application
1.5.1 Global Bronchitis Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bronchitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Bronchitis Drug Revenue 2015-2026
2.1.2 Global Bronchitis Drug Sales 2015-2026
2.2 Global Bronchitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bronchitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bronchitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bronchitis Drug Competitor Landscape by Players
3.1 Bronchitis Drug Sales by Manufacturers
3.1.1 Bronchitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Bronchitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Bronchitis Drug Revenue by Manufacturers
3.2.1 Bronchitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Bronchitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bronchitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bronchitis Drug Revenue in 2019
3.2.5 Global Bronchitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bronchitis Drug Price by Manufacturers
3.4 Bronchitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Bronchitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bronchitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Bronchitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bronchitis Drug Market Size by Type (2015-2020)
4.1.1 Global Bronchitis Drug Sales by Type (2015-2020)
4.1.2 Global Bronchitis Drug Revenue by Type (2015-2020)
4.1.3 Bronchitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bronchitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Bronchitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Bronchitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Bronchitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bronchitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bronchitis Drug Market Size by Application (2015-2020)
5.1.1 Global Bronchitis Drug Sales by Application (2015-2020)
5.1.2 Global Bronchitis Drug Revenue by Application (2015-2020)
5.1.3 Bronchitis Drug Price by Application (2015-2020)
5.2 Bronchitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Bronchitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Bronchitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Bronchitis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bronchitis Drug by Country
6.1.1 North America Bronchitis Drug Sales by Country
6.1.2 North America Bronchitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bronchitis Drug Market Facts & Figures by Type
6.3 North America Bronchitis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Bronchitis Drug by Country
7.1.1 Europe Bronchitis Drug Sales by Country
7.1.2 Europe Bronchitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bronchitis Drug Market Facts & Figures by Type
7.3 Europe Bronchitis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bronchitis Drug by Region
8.1.1 Asia Pacific Bronchitis Drug Sales by Region
8.1.2 Asia Pacific Bronchitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bronchitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Bronchitis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bronchitis Drug by Country
9.1.1 Latin America Bronchitis Drug Sales by Country
9.1.2 Latin America Bronchitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bronchitis Drug Market Facts & Figures by Type
9.3 Central & South America Bronchitis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bronchitis Drug by Country
10.1.1 Middle East and Africa Bronchitis Drug Sales by Country
10.1.2 Middle East and Africa Bronchitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bronchitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Bronchitis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Advanced Inhalation Therapies (AIT) Ltd
11.1.1 Advanced Inhalation Therapies (AIT) Ltd Corporation Information
11.1.2 Advanced Inhalation Therapies (AIT) Ltd Description and Business Overview
11.1.3 Advanced Inhalation Therapies (AIT) Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Products Offered
11.1.5 Advanced Inhalation Therapies (AIT) Ltd Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Bronchitis Drug Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 DBV Technologies SA
11.3.1 DBV Technologies SA Corporation Information
11.3.2 DBV Technologies SA Description and Business Overview
11.3.3 DBV Technologies SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 DBV Technologies SA Bronchitis Drug Products Offered
11.3.5 DBV Technologies SA Related Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Ltd Bronchitis Drug Products Offered
11.4.5 F. Hoffmann-La Roche Ltd Related Developments
11.5 Han Wha Pharma Co Ltd
11.5.1 Han Wha Pharma Co Ltd Corporation Information
11.5.2 Han Wha Pharma Co Ltd Description and Business Overview
11.5.3 Han Wha Pharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Han Wha Pharma Co Ltd Bronchitis Drug Products Offered
11.5.5 Han Wha Pharma Co Ltd Related Developments
11.6 Kyorin Pharmaceutical Co Ltd
11.6.1 Kyorin Pharmaceutical Co Ltd Corporation Information
11.6.2 Kyorin Pharmaceutical Co Ltd Description and Business Overview
11.6.3 Kyorin Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Kyorin Pharmaceutical Co Ltd Bronchitis Drug Products Offered
11.6.5 Kyorin Pharmaceutical Co Ltd Related Developments
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Corporation Information
11.7.2 Merck & Co Inc Description and Business Overview
11.7.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck & Co Inc Bronchitis Drug Products Offered
11.7.5 Merck & Co Inc Related Developments
11.8 Mucosis BV
11.8.1 Mucosis BV Corporation Information
11.8.2 Mucosis BV Description and Business Overview
11.8.3 Mucosis BV Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mucosis BV Bronchitis Drug Products Offered
11.8.5 Mucosis BV Related Developments
11.9 Orbis Biosciences Inc
11.9.1 Orbis Biosciences Inc Corporation Information
11.9.2 Orbis Biosciences Inc Description and Business Overview
11.9.3 Orbis Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Orbis Biosciences Inc Bronchitis Drug Products Offered
11.9.5 Orbis Biosciences Inc Related Developments
11.10 Therabron Therapeutics Inc
11.10.1 Therabron Therapeutics Inc Corporation Information
11.10.2 Therabron Therapeutics Inc Description and Business Overview
11.10.3 Therabron Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Therabron Therapeutics Inc Bronchitis Drug Products Offered
11.10.5 Therabron Therapeutics Inc Related Developments
11.1 Advanced Inhalation Therapies (AIT) Ltd
11.1.1 Advanced Inhalation Therapies (AIT) Ltd Corporation Information
11.1.2 Advanced Inhalation Therapies (AIT) Ltd Description and Business Overview
11.1.3 Advanced Inhalation Therapies (AIT) Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Products Offered
11.1.5 Advanced Inhalation Therapies (AIT) Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bronchitis Drug Market Estimates and Projections by Region
12.1.1 Global Bronchitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Bronchitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Bronchitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Bronchitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Bronchitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Bronchitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Bronchitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Bronchitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Bronchitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Bronchitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bronchitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bronchitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bronchitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bronchitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Bronchitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Bronchitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Bronchitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Bronchitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bronchitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bronchitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bronchitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bronchitis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bronchitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bronchitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bronchitis Drug Market Segments
Table 2. Ranking of Global Top Bronchitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bronchitis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AZD-9668
Table 5. Major Manufacturers of CG-367
Table 6. Major Manufacturers of Cyclosporine
Table 7. Major Manufacturers of HOB-051
Table 8. Major Manufacturers of Others
Table 9. Global Bronchitis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Bronchitis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Bronchitis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Bronchitis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Bronchitis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Bronchitis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Bronchitis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Bronchitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Bronchitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchitis Drug as of 2019)
Table 18. Bronchitis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Bronchitis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Bronchitis Drug Price (2015-2020) (USD/Pcs)
Table 21. Bronchitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bronchitis Drug Product Type
Table 23. Date of International Manufacturers Enter into Bronchitis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Bronchitis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Bronchitis Drug Sales Share by Type (2015-2020)
Table 27. Global Bronchitis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Bronchitis Drug Revenue Share by Type (2015-2020)
Table 29. Bronchitis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Bronchitis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Bronchitis Drug Sales Share by Application (2015-2020)
Table 32. North America Bronchitis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Bronchitis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Bronchitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Bronchitis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Bronchitis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Bronchitis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Bronchitis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Bronchitis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Bronchitis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Bronchitis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Bronchitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Bronchitis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Bronchitis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Bronchitis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Bronchitis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Bronchitis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Bronchitis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Bronchitis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Bronchitis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Bronchitis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Bronchitis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Bronchitis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Bronchitis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Bronchitis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Bronchitis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Bronchitis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Bronchitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Bronchitis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Bronchitis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Bronchitis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Bronchitis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Bronchitis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Bronchitis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Bronchitis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Bronchitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Bronchitis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Bronchitis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Bronchitis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Bronchitis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Bronchitis Drug Sales Market Share by Application (2015-2020)
Table 72. Advanced Inhalation Therapies (AIT) Ltd Corporation Information
Table 73. Advanced Inhalation Therapies (AIT) Ltd Description and Major Businesses
Table 74. Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Advanced Inhalation Therapies (AIT) Ltd Product
Table 76. Advanced Inhalation Therapies (AIT) Ltd Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. DBV Technologies SA Corporation Information
Table 83. DBV Technologies SA Description and Major Businesses
Table 84. DBV Technologies SA Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. DBV Technologies SA Product
Table 86. DBV Technologies SA Recent Development
Table 87. F. Hoffmann-La Roche Ltd Corporation Information
Table 88. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 89. F. Hoffmann-La Roche Ltd Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. F. Hoffmann-La Roche Ltd Product
Table 91. F. Hoffmann-La Roche Ltd Recent Development
Table 92. Han Wha Pharma Co Ltd Corporation Information
Table 93. Han Wha Pharma Co Ltd Description and Major Businesses
Table 94. Han Wha Pharma Co Ltd Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Han Wha Pharma Co Ltd Product
Table 96. Han Wha Pharma Co Ltd Recent Development
Table 97. Kyorin Pharmaceutical Co Ltd Corporation Information
Table 98. Kyorin Pharmaceutical Co Ltd Description and Major Businesses
Table 99. Kyorin Pharmaceutical Co Ltd Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Kyorin Pharmaceutical Co Ltd Product
Table 101. Kyorin Pharmaceutical Co Ltd Recent Development
Table 102. Merck & Co Inc Corporation Information
Table 103. Merck & Co Inc Description and Major Businesses
Table 104. Merck & Co Inc Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Merck & Co Inc Product
Table 106. Merck & Co Inc Recent Development
Table 107. Mucosis BV Corporation Information
Table 108. Mucosis BV Description and Major Businesses
Table 109. Mucosis BV Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Mucosis BV Product
Table 111. Mucosis BV Recent Development
Table 112. Orbis Biosciences Inc Corporation Information
Table 113. Orbis Biosciences Inc Description and Major Businesses
Table 114. Orbis Biosciences Inc Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Orbis Biosciences Inc Product
Table 116. Orbis Biosciences Inc Recent Development
Table 117. Therabron Therapeutics Inc Corporation Information
Table 118. Therabron Therapeutics Inc Description and Major Businesses
Table 119. Therabron Therapeutics Inc Bronchitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Therabron Therapeutics Inc Product
Table 121. Therabron Therapeutics Inc Recent Development
Table 122. Global Bronchitis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 123. Global Bronchitis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Bronchitis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Bronchitis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Bronchitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. North America: Bronchitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Bronchitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Europe: Bronchitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Bronchitis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 131. Asia Pacific: Bronchitis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Bronchitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Latin America: Bronchitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Bronchitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Middle East and Africa: Bronchitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Bronchitis Drug Players
Table 140. Bronchitis Drug Customers List
Table 141. Bronchitis Drug Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Bronchitis Drug Product Picture
Figure 2. Global Bronchitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AZD-9668 Product Picture
Figure 4. CG-367 Product Picture
Figure 5. Cyclosporine Product Picture
Figure 6. HOB-051 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Bronchitis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Homecare
Figure 12. Bronchitis Drug Report Years Considered
Figure 13. Global Bronchitis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Bronchitis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Bronchitis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Bronchitis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Bronchitis Drug Sales Market Share by Region in 2019
Figure 18. Global Bronchitis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Bronchitis Drug Revenue Market Share by Region in 2019
Figure 20. Global Bronchitis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Bronchitis Drug Revenue in 2019
Figure 22. Bronchitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Bronchitis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Bronchitis Drug Sales Market Share by Type in 2019
Figure 25. Global Bronchitis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Bronchitis Drug Revenue Market Share by Type in 2019
Figure 27. Global Bronchitis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Bronchitis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Bronchitis Drug Sales Market Share by Application in 2019
Figure 30. Global Bronchitis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Bronchitis Drug Revenue Market Share by Application in 2019
Figure 32. North America Bronchitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Bronchitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Bronchitis Drug Sales Market Share by Country in 2019
Figure 35. North America Bronchitis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Bronchitis Drug Market Share by Type in 2019
Figure 41. North America Bronchitis Drug Market Share by Application in 2019
Figure 42. Europe Bronchitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Bronchitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Bronchitis Drug Sales Market Share by Country in 2019
Figure 45. Europe Bronchitis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Bronchitis Drug Market Share by Type in 2019
Figure 57. Europe Bronchitis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Bronchitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Bronchitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Bronchitis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Bronchitis Drug Revenue Market Share by Region in 2019
Figure 62. China Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Bronchitis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Bronchitis Drug Market Share by Application in 2019
Figure 86. Latin America Bronchitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Bronchitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Bronchitis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Bronchitis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Bronchitis Drug Market Share by Type in 2019
Figure 97. Latin America Bronchitis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Bronchitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Bronchitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Bronchitis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Bronchitis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Bronchitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Bronchitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Bronchitis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Bronchitis Drug Market Share by Application in 2019
Figure 110. North America Bronchitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Bronchitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Bronchitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Bronchitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Bronchitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Bronchitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Bronchitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Bronchitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Bronchitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Bronchitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
気管支炎治療の世界市場（～2026年） Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue, shortness o…- 肺ドラッグデリバリーシステム（PDDS）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Drug Delivery System (PDDS) Market The global Pulmonary Drug Delivery System (PDDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Drug Delivery System (PDDS) S…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 子宮内膜ポリープ治療薬の世界市場（～2026年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …
- 子宮筋腫治療薬の世界市場（～2026年） Uterine fibroids are the most common benign tumors in female reproductive organs and one of the most common tumors in human body. They are mainly caused by proliferation of uterine smooth muscle cells. Market Analysis and Insights: Global Uterine Fibroids Drug Market The global Uterine Fibroids Drug…